SCHEMBL30066459

SCHEMBL30066459

c1ccc2[nH]c(-n3ncc4c3CCCC4)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.42
▸ DHODH Q02127 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ KIF11 P52732 1/20 0.35
▸ HRH4 Q9H3N8 3/20 0.33
▸ AOC3 Q16853 2/20 0.33
▸ FGFR1 P11362 3/20 0.33
▸ SRC P12931 3/20 0.33
▸ FGFR2 P21802 3/20 0.33
▸ FGFR4 P22455 3/20 0.33
▸ FGFR3 P22607 3/20 0.33
▸ KDR P35968 3/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ PAX8 Q06710 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30066339 0.80 KDM4E (0.39) MAPK14DHODHHRH3HRH4FGFR1
SCHEMBL5635166 0.73 CYP11B1 (0.40) AOC3FGFR1SRCFGFR2FGFR4
SCHEMBL7961456 0.71 USP7 (0.51) HDAC8NPC1RAB9AKDM4E
SCHEMBL15838966 0.68 CYP11B1 (0.49) —
SCHEMBL23934809 0.66 USP7 (0.56) MAPK14DHODHNPC1RAB9A
SCHEMBL18850703 0.66 HDAC9 (0.46) MAPK14DHODHNPC1
SCHEMBL7715904 0.66 TSHR (0.46) HRH3AOC3KDM4E
SCHEMBL8087823 0.65 HRH3 (0.50) HRH3HRH4AOC3NPC1RAB9A
SCHEMBL29684111 0.64 HRH3 (0.49) HRH3HRH4AOC3NPC1RAB9A
SCHEMBL2940750 0.64 HRH3 (0.49) HRH3HRH4AOC3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334303-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE Nurix Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback